Location: Ireland
Total raised: $2.92M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.10.2025 | - | $2.92M | - |
Mentions in press and media 2
| Date | Title | Description |
| 03.10.2025 | UCC spin-out ProVascTec secures €2.5m DTIF funding for breakthrough vascular therapy | A Cork-based UCC spin-out has been awarded €2.5m under the latest round of Enterprise Ireland’s Disruptive Technologies Innovation Fund (DTIF) to develop a new treatment for severe arterial blockages. ProVascTec, based at the UCC Gateway In... |
| 20.03.2023 | INTRODUCING PROVASCTEC : A CELL THERAPY FOR PATIENTS WITH CRITICAL LIMB ISCHEMIA | March 20, 2023 Atherosclerosis describes the build-up of fats, cholesterol and other substances within the inner arterial walls. This build-up, also called plaque, can cause arteries to narrow and eventually completely block the arterial b... |